srch

29.12.2021 · Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines.

Regeneron Pharmaceuticals, Inc. er et amerikansk bioteknologisk selskap med hovedsete i Tarrytown i New York i USA. Det ble grunnlagt i 1988. Det fokuserte opprinnelig på nevrotropiske faktorer og deres regenerative evner (hvorav selskapets navn), og forgrenet seg etterhvert til studier av både cytokin- og tyrosin kinase-reseptorer.

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work together to discover, invent, ...

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York, about 25 miles north of Midtown Manhattan. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kina…

Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need. Learn more.

Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need. Learn more.

Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock quote, history, news and other vital information to help you with your stock trading and ...

View the latest Regeneron Pharmaceuticals Inc. (REGN) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of ...

Regenerons hovedsete. Regeneron Pharmaceuticals, Inc. er et amerikansk bioteknologisk selskap med hovedsete i Tarrytown i New York i USA. Det ble grunnlagt i ...

22.12.2021 · Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in …